Oncology
Research focused on understanding and treating cancer, including solid tumours and haematologic malignancies. Advances in immunotherapy, particularly in immuno-oncology, are harnessing the power of the immune system to target and destroy cancer cells. Innovations in targeted therapies and precision medicine are transforming patient outcomes and offering new hope in the fight against many cancer types.
Cardiovascular Diseases
Exploration of conditions affecting the heart and blood vessels, such as hypertension, heart failure and atherosclerosis. Innovations include regenerative medicine, gene therapy and advanced diagnostic tools to reduce morbidity and mortality worldwide.
Neurology
Study and treatment of disorders affecting the nervous system, such as Alzheimer’s disease, Parkinson’s disease and epilepsy. Cutting-edge research in neurodegeneration, neuroinflammation and brain-machine interfaces is paving the way for better management of neurological conditions.
Infectious Diseases
Development of therapies and vaccines to combat bacterial, viral and parasitic infections, including emerging diseases such as COVID-19. Research spans antimicrobial resistance, novel antivirals and strategies to improve global health through better immunity.
Immunology
Understanding the immune system and its role in health and disease, including autoimmune disorders such as rheumatoid arthritis and systemic lupus erythematosus. Breakthroughs in immune modulation and biologics are offering targeted solutions for complex immune-mediated diseases.
Metabolic Diseases
Focus on conditions such as diabetes, obesity and metabolic syndrome, which affect millions of people worldwide. Research includes metabolic pathways, novel drug targets and lifestyle interventions to improve disease management and patients’ quality of life.
Vaccinology
The science of vaccine development and deployment, addressing diseases such as influenza, HPV and COVID-19. Innovations in mRNA technology, adjuvants and delivery systems are revolutionising prevention and global health strategies.
Hematology
Study of the blood and blood-forming organs, focusing on disorders such as anaemia, haemophilia and leukaemia. Innovations in bone-marrow transplants, gene therapy and blood-product development are revolutionising the treatment and understanding of haematologic diseases.
Rare Diseases
Investigation of conditions affecting fewer than 1 in 2,000 people, such as cystic fibrosis and Huntington’s disease. Efforts focus on understanding genetic causes, developing orphan drugs and creating tailored therapies to improve patient care and quality of life.
